Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a strategic partnership to deliver a ...

Many Bright Ideas Technologies Inc. company and executive profile by Barron's. View the latest MBI.H company infomation and executive bios.

No direct holdings were involved in the transaction; all shares are held indirectly via trusts or similar entities. This purchase follows a prior net buying trend, with capacity-driven increases as ...

Stonegate Healthcare Partners releases a comprehensive research report comparing Sirona Biochem's TFC-1326 to traditional retinoids, revealing superior performance in skin rejuvenation with enhanced ...

Stonegate Capital Partners has begun coverage of Sirona Biochem Corp, emphasizing the company's promising position in the premium skincare market and its path to profitability by 2025. Stonegate ...

Sirona Biochem Corp. Annual cash flow by MarketWatch. View SBM.H net cash flow, operating cash flow, operating expenses and cash dividends.

Exact Sciences is acquiring exclusive U.S. rights to Freenome’s blood-based colon cancer screening test for $75 million upfront, with up to $700 million in milestone payments. SERB Pharmaceuticals ...

VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company’s financial ...